基本信息
文件名称:5A2-SC8-TFA-生命科学试剂-MCE.pdf
文件大小:658.9 KB
总页数:2 页
更新时间:2025-05-24
总字数:约3.22千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

5A2-SC8TFA

Cat.No.:HY-145799A

分?式:C??H???N?O??S?.xC?HF?O?

作?靶点:Liposome

作?通路:MetabolicEnzyme/Protease

储存?式:-20°C,sealedstorage,awayfrommoistureandlight

*Insolvent:-80°C,6months;-20°C,1month(sealed

storage,awayfrommoistureandlight)

BIOLOGICALACTIVITY

?物活性5A2-SC8TFA是?种脂质纳?粒?(LNPs)中的可电离氨基脂质,显?出?效的递送潜?和较低的体内毒性

,能够将?RNA(如siRNA和miRNA)有效地递送到肿瘤细胞中。5A2-SC8TFALNPs可以赋予RNA在肝脏内

独特的递送命运,从?改变癌症模型的治疗结果[1][2][3]。

体外研究TheApoEproteincoronaadsorbsonthesurfaceof5A2-SC8LNPsbindstoLDL-Ronthesurfaceof

hepatocytesandundergoesreceptor-mediatedendocytosis,andistakenupbyhepatocytes[2].

体内研究5A2-SC8(75mg/kg;i.v.;single-dose)iswelltoleratedanddoesnotaffectsurvivalinmicewithchronic

aggressivehepatocellularcarcinoma[1].5A2-SC8(0.5mg/kg;i.v.;single-dose)canpassthefirstbarrierof

KupffercellsintheliverandbeinternalizedintohepatocytesinthepresenceofsiFVIIlabeledwithCy5.5dye

[2].

客户使?本产品发表的科研?献

?Pharmaceutics.2022,14(10),2129.

Seemorecustomervalidationsonwww.MedChemE

REFERENCES

[1].ZhouK,NguyenLH,MillerJB,etal.Modulardegradabledendrimersenablesmall